Travel medicine: Key to improved adult vaccination against hepatitis A and B

Journal of Travel Medicine

Volumn 8, Issue SUPPL. 1, 2001, Pages s1-s2

  Ericsson, C D ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE;

ADULT; DEVELOPING COUNTRY; EDITORIAL; ENDEMIC DISEASE; ENVIRONMENTAL SANITATION; HEPATITIS A; HEPATITIS B; HUMAN; INFECTION RISK; SEXUAL TRANSMISSION; TRAVEL; VACCINATION; VERTICAL TRANSMISSION;

EID: 0035084392     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2001.tb00537.x     Document Type: Editorial

References (9)

1. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: Rationale and summary of findings
2. High immunogenicity and good tolerability of a new hepatitis A vaccine candidate
3. Accelerated schedule for hepatitis B immunization
4. Immunogenicity, reactogenicity and persistence of a combined hepatitis A and B vaccine compared with monovalent hepatitis A and B vaccines according to an accelerated schedule of 0, 7 and 21 days
5. Inactivated hepatitis A vaccine reactogenicity, immunogenicity, and long-term antibody persistence
6. Long-term immunity to hepatitis B infection after vaccination with recombinant hepatitis B vaccine
7. Inactivated hepatitis A vaccine: Long-term antibody persistence
8. Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule)
9. Vaccination of travelers against hepatitis A and B